Published on
December 3, 2021
- 13:04 GMT
Revised Regulations Allow Oral Biologics And Biosimilars Companies To Employ New Technologies And Testing Methods
The Business Research Company’s Oral Biologics And Biosimilars Market - Opportunities And Strategies - Global Forecast To 2030 LONDON, GREATER LONDON, UK, December 3, 2021 /EINPresswire.com/ -- The US Food and Drug Administration (FDA) has revised its …
Distribution channels:
Healthcare & Pharmaceuticals Industry, International Organizations
...
